" class="no-js "lang="en-US"> Verana Health - Medtech Alert
Monday, September 08, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Verana Health | Pharmtech Focus

Verana Health

About Verana Health

Verana Health

Verana Health exists to accelerate medical research by empowering the healthcare community with data insights. We are a team of technologists and healthcare enthusiasts committed to bringing the best treatments and care possible to patients by learning from the experience of all patients.

Related Story

Diseases

 Verana Health Announces the Qdata Parkinson's Disease Module at 2023 AAN Annual Meeting | MTA

Verana Health Announces the Qdata Parkinson's Disease Module at 2023 AAN Annual Meeting

April 24 2023

Verana Health, a digital health company elevating quality in real-world data (RWD), has announced it’s […]

Appointments

 Verana Health Fuels for Growth with the Appointment of Chris Reiling as Chief Revenue Officer and Lawrence Whittle as Chief Commercial Officer | Pharmtech Focus

Verana Health Fuels for Growth with the Appointment of Chris Reiling as Chief Revenue Officer and Lawrence Whittle as Chief Commercial Officer

August 3 2022

Verana Health®—a digital health company elevating quality in real-world data—today announced the appointments of Chris Reiling as […]

Fundraising

 Verana Health Secures $150M Series E Funding Round | Pharmtech Focus

Verana Health Secures $150M Series E Funding Round

January 17 2022

Verana Health, a digital health company that delivers quality drug lifecycle and medical practice insights […]

Fundraising

 Digital Health Leader Verana Health Secures $150M Series E Funding Round | Pharmtech Focus

Digital Health Leader Verana Health Secures $150M Series E Funding Round

January 14 2022

Verana Health, a digital health company that delivers quality drug lifecycle and medical practice insights […]

Appointments

 Veralox Therapeutics Appoints Michael Hanna as Chief Medical Officer | Pharmtech Focus

Veralox Therapeutics Appoints Michael Hanna as Chief Medical Officer

June 24 2021

Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies […]

Clinical Trials

 Verana Health Leads First-of-its-Kind Study Demonstrating Promise of Real-World Data in Ophthalmic Clinical Development | Pharmtech Focus

Verana Health Leads First-of-its-Kind Study Demonstrating Promise of Real-World Data in Ophthalmic Clinical Development

May 24 2021

Verana Health, a healthcare technology and analytics innovator transforming multi-specialty clinical data into real-world evidence, […]